Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 plus trastuzumab and vinorelbine in HER2-positive trastuzumab-resistant advanced breast cancer
CTR20130851Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by Novartis. Started Mar 2015; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20130851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130851.